TABLE 2

PCa-to-Tissue Accumulation Ratios of Anti-¹⁸F-FACBC and ¹⁸F-FDG in DPCI Rats (n = 3)

	Anti-¹⁸F-FACBC		¹⁸F-FDG
Tissue^*	15 min	60 min	15 min	60 min
Urinary bladder^†	0.78 ± 0.59^‡	0.54 ± 0.12^‡	0.02 ± 0.01	0.02 ± 0.01
Blood	3.30 ± 0.56^‡	3.71 ± 0.78	1.33 ± 0.10	4.73 ± 0.34
Muscle	5.14 ± 0.99	3.25 ± 0.39^‡	5.13 ± 0.56	7.18 ± 3.91
Bone	2.49 ± 0.49	2.80 ± 0.76	1.95 ± 0.41	1.87 ± 0.62
Lymph node	3.32 ± 1.39^‡	4.13 ± 0.83^‡	1.34 ± 0.30	1.56 ± 0.51
Lung	1.69 ± 0.16^‡	1.93 ± 0.28	1.36 ± 0.20	1.69 ± 0.53
Liver	0.83 ± 0.26^‡	1.01 ± 0.16^‡	1.35 ± 0.12	4.98 ± 1.15
Brain	8.56 ± 0.39^‡	4.16 ± 0.83^‡	0.59 ± 0.19	0.47 ± 0.15

↵* All ratios were calculated from values of %ID/g, except for ratio of PCa to urinary bladder.
↵† Ratios were calculated from values of %ID/cm³.
↵‡ P < 0.05, anti-¹⁸F-FACBC vs. ¹⁸F-FDG at 15 and 60 min after injection.
Data are presented as mean ± SD.